The global alcohol-related liver disease treatment market is poised for remarkable growth in the coming years. Driven by factors such as a increasing prevalence of alcohol abuse and an maturing population, demand for effective treatments is soaring. Key players in the market are devoting resources to create innovative therapies and widen their geo